Cost-effectiveness of implantable cardioverter-defibrillators for primary prevention of sudden cardiac death-Reference-Cited by-同舟云学术

Cost-effectiveness of implantable cardioverter-defibrillators for primary prevention of sudden cardiac death

Published:2022-01 Issue:1 Volume:75 Page:12-21
ISSN:1885-5857
Container-title:Revista Española de Cardiología (English Edition)
language:en
Short-container-title:Revista Española de Cardiología (English Edition)

Author:

Ribera Aida,Giménez Emmanuel,Oristrell Gerard,Osorio Dimelza,Marsal Josep Ramón,García-Pérez Lidia,Ballesteros Mónica,Ródenas Eduard,Belahnech Yassin,Escalona Roxana,Rivas Núria,Roca-Luque Ivo,Ferreira-González Ignacio,Espallargues Mireia

Funder

Ministerio de Sanidad, Consumo y Bienestar Social

Publisher

Elsevier BV

Subject

General Medicine

Reference47 articles.

1. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death;Priori;Eur Heart J.,2015

2. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction;Moss;N Engl J Med.,2002

3. Amiodarone or an implantable cardioverter–defibrillator for congestive heart failure;Bardy;N Engl J Med.,2005

4. Defibrillator implantation in patients with nonischemic systolic heart failure;Køber;N Engl J Med.,2016

5. New York Heart Association class and the survival benefit from primary prevention implantable cardioverter defibrillators: A pooled analysis of 4 randomized controlled trials;Friedman;Am Heart J.,2017

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Primary prevention implantable cardioverter-defibrillator use in non-ischemic dilated cardiomyopathy based on arrhythmic risk stratification and left ventricular reverse remodeling prediction;Heart Failure Reviews;2022-05-19